-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Enlivex Therapeutics Ltd. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2024.
- Enlivex Therapeutics Ltd. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.16 USD/shares, a 56.8% increase year-over-year.
- Enlivex Therapeutics Ltd. annual Earnings Per Share, Basic for 2023 was -1.56 USD/shares, a 7.69% increase from 2022.
- Enlivex Therapeutics Ltd. annual Earnings Per Share, Basic for 2022 was -1.69 USD/shares, a 109% decline from 2021.
- Enlivex Therapeutics Ltd. annual Earnings Per Share, Basic for 2021 was -0.81 USD/shares, a 10% increase from 2020.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)